Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
A Ray; D S Das; Y Song; T Hideshima; Y-T Tai; D Chauhan; K C Anderson
Author Information: The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.